Cargando…
Molecularly targeted therapy for the treatment of head and neck cancer: a review of the ErbB family inhibitors
The majority of patients with head and neck squamous cell carcinoma (HNSCC) present with locally advanced disease, which requires site-specific combinations of surgery, radiation, and chemotherapy. Despite aggressive therapy, survival outcomes remain poor, and treatment-related morbidity is not negl...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831599/ https://www.ncbi.nlm.nih.gov/pubmed/27110122 http://dx.doi.org/10.2147/OTT.S93720 |